Fig. 13From: Transient effects of tumor location on the functional architecture at rest in glioblastoma patients: three longitudinal case studiesPercentage isodoses of 30 % (blue), 50 % (yellow), 70 % (green) and 90 % (red) of the maximum. a The dose for PAT_pCC has been maximized in the tumor in posterior part of the brain. b For PAT_mPFC the dose has been maximized in the tumor situated in the frontal lobe. c The dose for PAT_preCG has been maximized in the tumor near preCGBack to article page